Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?

[1] Baylis C(2008)Nitric oxide deficiency in chronic kidney disease Am J Physiol Renal Physiol 294 F1-F9

[2] Kanbay M(2011)Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease Am J Nephrol 33 298-304

[3] Yilmaz MI(2010)Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach J Am Soc Hypertens 4 116-127

[4] Sonmez A(2010)Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol 42 741-752

[5] Turgut F(1987)Prevention by calcitonin of the pathological modifications of the rabbit arterial wall induced by immunization with elastin peptides: effect on vascular smooth muscle permeability to ions Exp Mol Pathol 46 345-356

[6] Saglam M(2007)Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency J Am Soc Nephrol 18 613-620

[7] Cakir E(2006)Fat cell derived modulators of vascular cell pathophysiology: the list keeps growing J Cardiometab Syndr 1 121-124

[8] Yenicesu M(1999)A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann Intern Med 130 461-470

[9] Covic A(2010)FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease Kidney Int 78 679-685

[10] Jalal D(2006)The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine Am J Kidney Dis 47 42-50

[1] Baylis C(2008)Nitric oxide deficiency in chronic kidney disease Am J Physiol Renal Physiol 294 F1-F9

[2] Kanbay M(2011)Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease Am J Nephrol 33 298-304

[3] Yilmaz MI(2010)Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach J Am Soc Hypertens 4 116-127

[4] Sonmez A(2010)Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol 42 741-752

[5] Turgut F(1987)Prevention by calcitonin of the pathological modifications of the rabbit arterial wall induced by immunization with elastin peptides: effect on vascular smooth muscle permeability to ions Exp Mol Pathol 46 345-356

[6] Saglam M(2007)Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency J Am Soc Nephrol 18 613-620

[7] Cakir E(2006)Fat cell derived modulators of vascular cell pathophysiology: the list keeps growing J Cardiometab Syndr 1 121-124

[8] Yenicesu M(1999)A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann Intern Med 130 461-470

[9] Covic A(2010)FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease Kidney Int 78 679-685

[10] Jalal D(2006)The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine Am J Kidney Dis 47 42-50